Thu, Oct 18, 2012 at 13:16
Drugmaker Cipla has received a tentative U.S. FDA approval for its HIV treatment tablets, which have a combination of lamivudine, nevirapine and zidovudine drugs, the drug regulator's website showed.
Like this story, share it with millions of investors on M3
Cipla gets tentative US nod for HIV tablets
Drugmaker Cipla has received a tentative U.S. FDA approval for its HIV treatment tablets, which have a combination of lamivudine, nevirapine and zidovudine drugs, the drug regulator's website showed.
Like this story, share it with millions of investors on M3
Cipla gets tentative US nod for HIV tablets
Drugmaker Cipla has received a tentative U.S. FDA approval for its HIV treatment tablets, which have a combination of lamivudine, nevirapine and zidovudine drugs, the drug regulator's website showed.
Cipla sells the combination drug under the brand name 'Duovir N' outside the United States.
The company plans to use a different brand name in the US for this drug, S Radhakrishnan, a director on Cipla board told Reuters.
From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'
The latest earning numbers FIRST on CNBC-TV18
Anda sedang membaca artikel tentang
Cipla gets tentative US nod for HIV tablets
Dengan url
https://kesehatanda.blogspot.com/2012/10/cipla-gets-tentative-us-nod-for-hiv.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Cipla gets tentative US nod for HIV tablets
namun jangan lupa untuk meletakkan link
Cipla gets tentative US nod for HIV tablets
sebagai sumbernya
0 komentar:
Posting Komentar